Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

AvertD Post-Approval Study

Prescient Medicine Holdings, Inc. · with Caron Treatment Centers, Concentrics Research · NCT07135323

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18+ · All sexes
Healthy volunteers
Accepted
Study type
Observational
Target enrollment
4000
US sites recruiting
1
Study start
November 15, 2024
Record last updated
August 22, 2025

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

A Prospective Post-Approval Study of AvertD to Evaluate Device Performance, Prescribing Impact, and Labeling Comprehension in the Intended Use Population

Being studied: Opioid Used Disorder Risk Assessment

Conditions: Opioid Use Disorder

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • ≥18 years of age
  • Prior to first opioid prescription
  • Being considered for first oral opioid prescription (4-30 days)
  • Prescribed AvertD as part of care
  • Willing and able to complete yearly assessments for 5 years
  • Signed informed consent

Exclusion Criteria

  • Planned opioid prescription \<4 or >30 days
  • Any condition making participation unsafe or infeasible per investigator judgment

Recruiting US locations

Study contacts (from the official record)

  • Amanda Smith, MD · 800-800-5525 · amanda.smith@concentricsresearch.com
All healthy volunteers studies in Indiana →
AvertD Post-Approval Study (NCT07135323) | Bored Studies